Health

[ad_1] * The candidate vaccine was found to be more than 90% effective in preventing COVID-19 in participants with no evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis * Analysis evaluated 94 confirmed cases of COVID-19 in trial participants * The study recruited 43,538 participants, of whom …

[ad_1] SAO PAULO / BEIJING (Nov 10): Brazil’s health regulator suspended a clinical trial for China’s Sinovac coronavirus vaccine citing a serious adverse event, surprising trial organizers who responded that there had been one death, but It was not related to the vaccine. Health regulator Anvisa said on Monday the …

[ad_1] Previous lists: Oct 17 | Oct 18 | Oct 19 | Oct 20 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 26 | Oct 27 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 …

[ad_1] KUALA LUMPUR (Nov 10): While the world is celebrating Pfizer’s overnight announcement of a viable Covid-19 vaccine candidate, rubber glove stocks may not be part of the party. Glove counters top the losers list after the morning bell today. At 10:20 a.m., rubber glove counter stocks were among Bursa …

[ad_1] KUALA LUMPUR: Investors may rush to divest their glove stock holdings following news that trials of Pfizer’s Covid-19 vaccine have shown evidence of safe and effective inoculation against the virus. “We have already lowered the glove sector rating to ‘neutral from’ overweight ‘on August 25, 2020 due to positive …

[ad_1] KUALA LUMPUR: Issues related to the Covid-19 pandemic, as well as the implementation of the Conditional Movement Control Order (CMCO) in seven states since yesterday, are among the topics to be discussed today at Dewan Rakyat. According to Dewan Rakyat’s order documents, the two issues are contained in the …

[ad_1] © Bloomberg. BEIJING, CHINA – SEPTEMBER 24: A worker checks syringes of the potential CoronaVac vaccine on the Sinovac Biotech production line, where the company is producing its potential COVID-19 CoronaVac vaccine during a press tour on September 24, 2020 in Beijing, China. Sinovacs’ inactivated candidate vaccine, called CoronaVac, …

[ad_1] The Perikatan Nasional government’s decision to reactivate JASA, the Department of Special Affairs, and allocate RM85.5 million under the 2021 Budget has understandably caused a storm of outrage among the public. That money, as everyone says, can be better used to fight the Covid-19 pandemic, especially to obtain the …

[ad_1] KUALA LUMPUR: The opposition will only support the 2021 budget presented by the government if it really helps the people, Parti Keadilan Rakyat leader Anwar Ibrahim said on Monday (November 9) when starting the budget debate in parliament. In his speech, he stated that it is unclear how the …

[ad_1] NEW YORK (Reuters) – Work to distribute the COVID-19 experimental vaccine developed by Pfizer Inc. and BioNTech SE It is being geared up after companies announced successful interim data on Monday, but it won’t reach local pharmacies for the general public any time soon. The data, which sent US …